🏛️ Verified NIH Record • Updated 2024-12-12
CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab (NCT05121038)
A Phase 1B/2A Trial of CEND-1 in Combination with Neoadjuvant FOLFIRINOX Based Therapies in Pancreatic, Colon and Appendiceal Cancers (CENDIFOX)
🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic Sponsor: Anup Kasi
🩺 Plain-English Summary (8th-Grade Level)
This is a phase IB/IIA trial to ensure the safety of Certepetide (LSTA1/CEND-1) in combination with with Folfirinox with or without Panitumumab for treatment of pancreatic, colon and appendiceal cancers
Who can join: Review the eligibility criteria below.
Location: The University of Kansas Cancer Center (KUCC) — Fairway, Kansas
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- The University of Kansas Cancer Center (KUCC) — Fairway, Kansas
- The University of Kansas Cancer Center, Westwood Campus — Kansas City, Kansas
- The University of Kansas Medical Center — North Kansas City, Missouri
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Colon Cancer
- A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors — Basking Ridge, New Jersey
- Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality — Rochester, Minnesota
- The Exercise And Colorectal Cancer Treatment Trial — Baton Rouge, Louisiana
- Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer — Atlanta, Georgia
- The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer — Gilbert, Arizona
Explore by condition: All Colon Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.